Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Arrowhead Pharmaceuticals Ord Shs (NQ: ARWR)
42.01 USD  -0.70 (-1.64%)
Official Closing Price  /  Updated: 6:39 PM EDT, Aug 14, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 549,600
Open 42.61
Bid (Size) 41.10 (60)
Ask (Size) 42.54 (3)
Prev. Close 42.71
Today's Range 41.40 - 42.85
52wk Range 19.51 - 73.72
Shares Outstanding 87,577,188
Dividend Yield N/A
Performance
YTD
-33.44%
-33.44%
1 Month
-12.81%
-12.81%
3 Month
+17.18%
+17.18%
6 Month
+1.79%
+1.79%
1 Year
+43.97%
+43.97%
Top News
More News
Arrowhead Pharmaceuticals Initiates Dosing Phase 1/2 Study of ARO-ENaC for Treatment of Cystic Fibrosis
Arrowhead Pharmaceuticals Initiates Dosing Phase 1/2 Study of ARO-ENaC for Treatment of Cystic Fibrosis Read More
from Business Wire News Releases
Arrowhead Pharmaceuticals Reports Fiscal 2020 Third Quarter Results
Arrowhead Pharmaceuticals reports fiscal Q3 2020 earnings results and hosts conference call Read More
from Business Wire News Releases
More News
Read More
Arrowhead Pharmaceuticals Earns $20 Million Milestone Payment from Amgen for Start of Phase 2 Trial of AMG 890
from Business Wire News Releases
Arrowhead Pharmaceuticals Hosts Key Opinion Leader Webinar on ARO-ENaC for Treatment of Cystic Fibrosis
from Business Wire News Releases
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)
from Business Wire News Releases
Arrowhead Pharmaceuticals to Host Key Opinion Leader Webinar on ARO-ENaC for Treatment of Cystic Fibrosis
from Business Wire News Releases
Notable Friday Option Activity: CSCO, ARWR, APPN
category Stocks
from Market News Video
Arrowhead Pharmaceuticals to Webcast Fiscal 2020 Third Quarter Results
from Business Wire News Releases
Stocks Generating Improved Relative Strength: Arrowhead Pharma
from Investor's Business Daily
Analysts Expect EWMC Will Reach $67
category ETFs
from ETF Channel
Arrowhead Pharmaceuticals, Inc (ARWR) Q3 2020 Earnings Call Transcript
category Market News , ARWR
from Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.